Sensor Biocompatibility and Biofouling in Real-Time Monitoring
Gabriela Voskerician
Case Western Reserve University, Cleveland, Ohio
Search for more papers by this authorJames Anderson
Case Western Reserve University, Cleveland, Ohio
Search for more papers by this authorGabriela Voskerician
Case Western Reserve University, Cleveland, Ohio
Search for more papers by this authorJames Anderson
Case Western Reserve University, Cleveland, Ohio
Search for more papers by this authorAbstract
The development of reliable implantable electrochemical sensors for long-term continuous in vivo monitoring of clinically important analytes remains one of the great challenges of biomedical engineering technology today. Although significant advances in the intravascular and subcutaneous biosensor development have been achieved, the biological response to the implantable biosensors continues to have a limiting impact on the performance and lifetime of such sensors, preventing their long-term use in real-time monitoring of critical analytes. Here, we examine the current status of research and development in this area, emphasizing the effect of the inflammatory and wound healing response on sensor biofouling. Also, the biocompatibility aspects of sensor implantation are discussed, as they are part of the inseparable dynamic continuum of biocompatibility and biofouling initiated by the presence of any foreign material/device in vivo.
Bibliography
- 1D. Fraser, An introduction to in vivo biosensing: progress and problems. In: D. Fraser, ed., Biosensors in the Body, Continuous in vivo Monitoring. Chichester, UK: John Wiley & Sons, 1997, pp. 1–56.
- 2A. Chaubey and B. D. Malhotra, Mediated biosensors. Biosens. Bioelectron. 2002; 17(6–7): 441–456.
- 3C.C. Liu, Electrochemical sensors. In: J. D. Bronzino, ed., The Biomedical Engineering Handbook. Boca Raton, FL: CRC Press, 1995, pp. 759–763.
- 4T. Kokubo, et al., Bioactive metals: preparation and properties. J. Mater. Sci. Mater. Med. 2004; 15(2): 99–107.
- 5T.C. Flanagan and A. Pandit, Living artificial heart valve alternatives: a review. Eur. Cell Mater. 2003; 6: 28–45(discussion 45).
- 6R. Bond, et al., Patches of different types for carotid patch angioplasty. Cochrane Database Syst. Rev. 2004; (jz):CD000071.
- 7N. Wisniewski, F. Moussy, and W. M. Reichert, Characterization of implantable biosensor membrane biofouling. Fresenius J. Anal. Chem. 2000; 366(6–7): 611–621.
- 8N. Wisniewski, et al., Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. J. Biomed. Mater. Res. 2001; 57(4): 513–521.
10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 9F. Moussy and W. M. Reichert, Biomaterials community examines biosensor biocompatibility. Diabetes Technol. Ther. 2000; 2(3): 473–477.
- 10G. Voskerician, Biological design criteria for implantable electrochemical devices. In: Biomedical Engineering. Cleveland, OH: Case Western Reserve University, 2004, p. 283.
- 11M. Kyrolainen, et al., Bio-/haemocompatibility: implications and outcomes for sensors? Acta Anaesthesiol. Scand. Suppl. 1995; 104: 55–60.
- 12C. J. Kirkpatrick, et al., Tissue response and biomaterial integration: the efficacy of in vitro methods. Biomol. Eng. 2002; 19(2–6): 211–217.
- 13B. D. Ratner, Replacing and renewing: synthetic materials, biomimetics, and tissue engineering in implant dentistry. J. Dent. Educ. 2001; 65(12): 1340–1347.
- 14J. M. Anderson, Biological responses to materials. Annu. Rev. Mater. Res. 2001; 31: 81–110.
- 15J.M. Anderson, Mechanisms of inflammation and infection with implanted devices. Cardiovasc. Pathol. 1993; 2(3): 33S–41S.
- 16C. P. Quinn, et al., Photo-crosslinked copolymers of 2-hydroxyethyl methacrylate, poly(ethylene glycol) tetra-acrylate and ethylene dimethacrylate for improving biocompatibility of biosensors. Biomaterials 1995; 16(5): 389–396.
- 17M. Gerritsen, et al., Biocompatibility evaluation of sol-gel coatings for subcutaneously implantable glucose sensors. Biomaterials 2000; 21(1): 71–78.
- 18X. Chen, et al., Electrochemically mediated electrodeposition/electropolymerization to yield a glucose microbiosensor with improved characteristics. Anal. Chem. 2002; 74: 368–372.
- 19F. Palmisano, et al., A disposable, reagentless, third-generation glucose biosensor based on overoxidized poly(pyrrole)/tetrathiafulvalene-tetracyanoquinodimethane composite. Anal. Chem. 2002; 74(23): 5913–5918.
- 20K. Ban, et al., Electrical communication between glucose oxidase and electrodes mediated by phenothiazine-labeled poly(ethylene oxide) bonded to lysine residues on the enzyme surface. Anal. Chem. 2003; 75(4): 910–917.
- 21W. K. Ward, et al., The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants. Biomaterials 2002; 23(21): 4185–4192.
- 22J. Anderson, Inflammation, wound healing, and the foreign body response. In: B. D. Ratner, ed., An Introduction to Materials in Medicine. San Diego, CA: Academic Press, 1996, pp. 165–173.
- 23J. G. Wagner and R. A. Roth, Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol. Rev. 2000; 52(3): 349–374.
- 24M. A. Williams and J. S. Solomkin, Integrin-mediated signaling in human neutrophil functioning. J. Leukoc. Biol. 1999; 65(6): 725–736.
- 25C. Rinder and J. Fitch, Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses. J. Cardiovasc. Pharmacol. 1996; 27(Suppl 1): S6–S12.
- 26J. J. Gray, The interaction of proteins with solid surfaces. Curr. Opin. Struct. Biol. 2004; 14(1): 110–115.
- 27B. D. Ratner and S. J. Bryant, Biomaterials: where we have been and where we are going. Annu. Rev. Biomed. Eng. 2004; 6: 41–75.
- 28A. S. Hoffman, Non-fouling surface technologies. J. Biomater. Sci. Polym. Ed. 1999; 10(10): 1011–1014.
- 29C. Werner and H. J. Jacobasch, Surface characterization of polymers for medical devices. Int. J. Artif. Organs 1999; 22(3): 160–176.
- 30N. J. Hallab, et al., Cell adhesion to biomaterials: correlations between surface charge, surface roughness, adsorbed protein, and cell morphology. J. Long Term Eff. Med. Implants 1995; 5(3): 209–231.
- 31J. M. Courtney, et al., Biomaterials for blood-contacting applications. Biomaterials 1994; 15(10): 737–744.
- 32L. Tang and J. W. Eaton, Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J. Exp. Med. 1993; 178(6): 2147–2156.
- 33W. J. Hu, et al., Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001; 98(4): 1231–1238.
- 34M. Schlosser and M. Ziegler, Biocompatibility of active implantable devices. In: D. Fraser, ed., Biosensors in The Body: Continuous In Vivo Monitoring. Chichester, UK: John Wiley & Sons, 1997, pp. 139–170.
- 35L. Tang, A. H. Lucas, and J. W. Eaton, Inflammatory responses to implanted polymeric biomaterials: role of surface-adsorbed immunoglobulin G. J. Lab. Clin. Med. 1993; 122(3): 292–300.
- 36J. M. Anderson, T. L. Bonfield, and N. P. Ziats, Protein adsorption and cellular adhesion and activation on biomedical polymers. Int. J. Artif. Organs 1990; 13(6): 375–382.
- 37T. O. Collier and J. M. Anderson, Protein and surface effects on monocyte and macrophage adhesion, maturation, and survival. J. Biomed. Mater. Res. 2002; 60(3): 487–496.
- 38W. J. Kao, Evaluation of protein-modulated macrophage behavior on biomaterials: designing biomimetic materials for cellular engineering. Biomaterials 1999; 20(23–24): 2213–2221.
- 39J. A. Hamilton, Nondisposable materials, chronic inflammation, and adjuvant action. J. Leukoc. Biol. 2003; 73(6): 702–712.
- 40J. Janatova, Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers. Asaio J. 2000; 46(6): S53–S62.
- 41J. M. Anderson, Multinucleated giant cells. Curr. Opin. Hematol. 2000; 7: 40–47.
- 42T. A. Heming, et al., Effects of extracellular pH on tumour necrosis factor-alpha production by resident alveolar macrophages. Clin. Sci. (Lond). 2001; 101(3): 267–274.
- 43G. Voskerician, et al., Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials 2003; 24(11): 1959–1967.
- 44G. Voskerician, et al., In vivo inflammatory and wound healing effects of gold electrode voltammetry for MEMS micro-reservoir drug delivery device. IEEE Trans. Biomed. Eng. 2004; 51(4): 627–635.
- 45R. S. Shawgo, et al., Repeated in vivo electrochemical activation and the biological effects of microelectromechanical systems drug delivery device. J. Biomed. Mater. Res. 2004; 71A(4): 559–568.
- 46S. B. Goodman, The effects of micromotion and particulate materials on tissue differentiation. Bone chamber studies in rabbits. Acta Orthop. Scand. Suppl. 1994; 258: 1–43.
- 47C. A. Chavrier and M. L. Couble, Ultrastructural immunohistochemical study of interstitial collagenous components of the healthy human keratinized mucosa surrounding implants Int. J. Oral Maxillofac. Implants. 1999; 14(1): 108–112.
- 48G. Voskerician, C. C. Liu, and J. M. Anderson, Electrochemical characterization and in vivo biocompatibility of thick film printed sensor for in vivo continuous monitoring. IEEE Sensors 2004, in press.
- 49A. A. Sharkawy, et al., Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J. Biomed. Mater. Res. 1998; 40(4): 598–605.
10.1002/(SICI)1097-4636(19980615)40:4<598::AID-JBM11>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- 50A. A. Sharkawy, et al., Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J. Biomed. Mater. Res. 1998; 40(4): 586–597.
10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 51A. A. Sharkawy, et al., Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J. Biomed. Mater. Res. 1997; 37(3): 401–412.
10.1002/(SICI)1097-4636(19971205)37:3<401::AID-JBM11>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 52M. C. Frost and M. E. Meyerhoff, Implantable chemical sensors for real-time clinical monitoring: progress and challenges. Curr. Opin. Chem. Biol. 2002; 6(5): 633–641.
- 53M. Gerritsen, Problems associated with subcutaneously implanted glucose sensors. Diabetes Care 2000; 23(2): 143–145.
- 54S. C. Conrad, J. J. Mastrototaro, and S. E. Gitelman, The use of a continuous glucose monitoring system in hypoglycemic disorders. J. Pediatr. Endocrinol. Metab. 2004; 17(3): 281–288.
- 55G. M. Steil, et al., Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol. Ther. 2003; 5(1): 27–31.
- 56M. Metzger, et al., Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 2002; 25(7): 1185–1191.
- 57E. Cheyne and D. Kerr, Making ‘sense’ of diabetes: using a continuous glucose sensor in clinical practice. Diabetes Metab. Res. Rev. 2002; 18(Suppl 1): S43–S48.
- 58E. Renard, et al., Implantable insulin pumps: infections most likely due to seeding from skin flora determine severe outcomes of pump-pocket seromas. Diabetes Metab. 2001; 27(1): 62–65.
- 59T. M. Gross, et al., Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol. Ther. 2000; 2(1): 49–56.
- 60T. M. Gross and J. J. Mastrototaro, Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol. Ther. 2000; 2(Suppl 1): S19–S26.
- 61J. J. Mastrototaro, The MiniMed continuous glucose monitoring system. Diabetes Technol. Ther. 2000; 2(Suppl 1): S13–S18.
- 62K. Rebrin, et al., Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am. J. Physiol. 1999; 277(3 Pt 1): E561–E571.
- 63B. W. Bode, et al., Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res. Clin. Pract. 1999; 46(3): 183–190.
- 64E. Renard, et al., Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility. Diabetes Care 1996; 19(8): 812–817.
- 65E. Renard, et al., Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials. Diabetes Care 1995; 18(3): 300–306.
- 66W. K. Ward, et al., A fully implantable subcutaneous glucose sensor array: enhanced accuracy from multiple sensing units and a median-based algorithm. Diabetes Technol. Ther. 2003; 5(6): 943–952.
- 67T. Chen, et al., In situ assembled mass-transport controlling micromembranes and their application in implanted amperometric glucose sensors. Anal. Chem. 2000; 72(16): 3757–3763.
- 68S. J. Updike, et al., A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000; 23(2): 208–214.
- 69W. K. Ward and J.E. Troupe, Assessment of chronically implanted subcutaneous glucose sensors in dogs: the effect of surrounding fluid masses. Asaio J. 1999; 45(6): 555–561.
- 70B. J. Gilligan, et al., Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care 1994; 17(8): 882–887.
- 71V. Thome-Duret, et al., Modification of the sensitivity of glucose sensor implanted into subcutaneous tissue. Diabetes Metab. 1996; 22(3): 174–178.
- 72W. K. Ward, M. D. Wood, and J. E. Troupe, Rise in background current over time in a subcutaneous glucose sensor in the rabbit: relevance to calibration and accuracy. Biosens. Bioelectron. 2000; 15(1–2): 53–61.
- 73C. Choleau, et al., Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients. Part 2. Superiority of the one-point calibration method. Biosens. Bioelectron. 2002; 17(8): 647–654.
- 74C. Choleau, et al., Calibration of a subcutaneous amperometric glucose sensor. Part 1. Effect of measurement uncertainties on the determination of sensor sensitivity and background current. Biosens. Bioelectron. 2002; 17(8): 641–646.
- 75T. von Woedtke, et al., Implantable glucose sensors: comparison between in vitro and in vivo kinetics. Int. J. Artif. Organs 1991; 14(8): 473–481.
- 76M. Koudelka, et al., In vivo behaviour of hypodermically implanted microfabricated glucose sensors. Biosens. Bioelectron. 1991; 6(1): 31–36.
- 77K. Rebrin, et al., Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality? J. Biomed. Eng. 1992; 14(1): 33–40.
- 78V. Poitout, et al., A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit. Diabetologia 1993; 36(7): 658–663.
- 79J. C. Pickup, D. J. Claremont, and G. W. Shaw, Responses and calibration of amperometric glucose sensors implanted in the subcutaneous tissue of man. Acta Diabetol. 1993; 30(3): 143–148.
- 80W. Kerner, et al., The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma. Biosens. Bioelectron. 1993; 8(9–10): 473–482.
- 81S. J. Updike, et al., Enzymatic glucose sensors. Improved long-term performance in vitro and in vivo. Asaio J. 1994; 40(2): 157–163.
- 82V. Poitout, D. Moatti-Sirat, and G. Reach, Development of a glucose sensor for glucose monitoring in man: the disposable implant concept. Clin. Mater. 1994; 15(4): 241–246.
- 83M. Shichiri, et al., Telemetry glucose monitoring device with needle-type glucose sensor: a useful tool for blood glucose monitoring in diabetic individuals. Diabetes Care 1986; 9(3): 298–301.
- 84S. Ertefai and D. A. Gough, Physiological preparation for studying the response of subcutaneously implanted glucose and oxygen sensors. J. Biomed. Eng. 1989; 11(5): 362–368.
- 85T. von Woedtke, et al., In situ calibration of implanted electrochemical glucose sensors. Biomed. Biochim. Acta 1989; 48(11–12): 943–952.
- 86J. C. Armour, et al., Application of chronic intravascular blood glucose sensor in dogs. Diabetes 1990; 39(12): 1519–1526.
- 87A. L. Aalders, et al., Development of a wearable glucose sensor; studies in healthy volunteers and in diabetic patients. Int. J. Artif. Organs 1991; 14(2): 102–108.
- 88V. Poitout, et al., In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor. ASAIO Trans. 1991; 37(3): M298–M300.
- 89J. L. Selam, External and implantable insulin pumps: current place in the treatment of diabetes. Exp. Clin. Endocrinol. Diabetes 2001; 109(Suppl 2): S333–S340.
- 90J. N. Roe and B. R. Smoller, Bloodless glucose measurements. Crit. Rev. Ther. Drug Carrier Syst. 1998; 15(3): 199–241.
- 91B. Aussedat, et al., Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am. J. Physiol. Endocrinol. Metab. 2000; 278(4): E716–E728.
- 92L. Heinemann and T. Koschinsky, Continuous glucose monitoring: an overview of today's technologies and their clinical applications. Int. J. Clin. Pract. Suppl. 2002; j129: 75–79.
- 93C. K. Mahutte, On-line arterial blood gas analysis with optodes: current status. Clin. Biochem. 1998; 31(3): 119–130.
- 94B. Venkatesh, T. H. Clutton-Brock, and S. P. Hendry, Continuous intra-arterial blood gas monitoring during cardiopulmonary resuscitation. Resuscitation 1995; 29(2): 135–138.
- 95L. W. Coule, et al., Accuracy and utility of a continuous intra-arterial blood gas monitoring system in pediatric patients. Crit. Care Med. 2001; 29(2): 420–426.
- 96M. Telting-Diaz, M. E. Collison, and M. E. Meyerhoff, Simplified dual-lumen catheter design for simultaneous potentiometric monitoring of carbon dioxide and pH. Anal. Chem. 1994; 66(4): 576–583.
- 97N. Holmstrom, et al., Long-term in vivo experience of an electrochemical sensor using the potential step technique for measurement of mixed venous oxygen pressure. Biosens. Bioelectron. 1998; 13(12): 1287–1295.
- 98P. A. Mills, et al., A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry. J. Appl. Physiol. 2000; 88(5): 1537–1544.
- 99W.K. Ward, M. D. Wood, and E. P. Slobodzian, Continuous amperometric monitoring of subcutaneous oxygen in rabbit by telemetry. J. Med. Eng. Technol. 2002; 26(4): 158–167.
- 100T. Schmitz-Rode, et al., Vascular capsule for telemetric monitoring of blood pressure. Rofo 2003; 175(2): 282–286.
- 101R. K. Meruva and M. E. Meyerhoff, Catheter-type sensor for potentiometric monitoring of oxygen, pH and carbon dioxide. Biosens. Bioelectron. 1998; 13(2): 201–212.
- 102M. C. Frost and M. E. Meyerhoff, Fabrication and in vivo evaluation of nitric oxide-releasing electrochemical oxygen-sensing catheters. Methods Enzymol. 2004; 381: 704–715.
- 103M. Gerritsen, et al., Performance of subcutaneously implanted glucose sensors: a review. J. Invest. Surg. 1998; 11(3): 163–174.
- 104M. M. Shavlovski, et al., Embryotoxicity of silver ions is diminished by ceruloplasmin-further evidence for its role in the transport of copper. Biometals 1995; 8(2): 122–128.
- 105W. F. Jackson and B. R. Duling, Toxic effects of silver-silver chloride electrodes on vascular smooth muscle. Circ. Res. 1983; 53(1): 105–108.
- 106A. Heller, Implanted electrochemical glucose sensors for the management of diabetes. Annu. Rev. Biomed. Eng. 1999; 1: 153–175.
- 107W. Kerner, Implantable glucose sensors: present status and future developments. Exp. Clin. Endocrinol. Diabetes 2001; 109(Suppl 2): S341–S346.
- 108M. M. Batchelor, et al., More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. J. Med. Chem. 2003; 46(24): 5153–5161.
- 109M. R. Schaffer, et al., Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. Surgery 1997; 121(5): 513–519.
- 110M. R. Schaffer, et al., Nitric oxide metabolism in wounds. J. Surg. Res. 1997; 71(1): 25–31.
- 111M. M. Reynolds, M. C. Frost, and M. E. Meyerhoff, Nitric oxide-releasing hydrophobic polymers: preparation, characterization, and potential biomedical applications. Free Radic. Biol. Med. 2004; 37(7): 926–936.
- 112B. K. Oh and M. E. Meyerhoff, Catalytic generation of nitric oxide from nitrite at the interface of polymeric films doped with lipophilic CuII-complex: a potential route to the preparation of thromboresistant coatings. Biomaterials 2004; 25(2): 283–293.
- 113M. C. Frost, et al., In vivo biocompatibility and analytical performance of intravascular amperometric oxygen sensors prepared with improved nitric oxide-releasing silicone rubber coating. Anal. Chem. 2002; 74(23): 5942–5947.
- 114H. Zhang, et al., Nitric oxide releasing silicone rubbers with improved blood compatibility: preparation, characterization, and in vivo evaluation. Biomaterials 2002; 23(6): 1485–1494.
- 115M. H. Schoenfisch, et al., Improving the thromboresistivity of chemical sensors via nitric oxide release: fabrication and in vivo evaluation of NO-releasing oxygen-sensing catheters. Anal. Chem. 2000; 72(6): 1119–1126.
- 116K. A. Mowery, et al., Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 2000; 21(1): 9–21.
- 117G. M. Annich, et al., Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit. Care. Med. 2000; 28(4): 915–920.
- 118W. K. Ward, et al., Vascularizing the tissue surrounding a model biosensor: how localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)? Biosens. Bioelectron. 2003; 19(3): 155–163.
- 119W. K. Ward, et al., The effect of local subcutaneous delivery of vascular endothelial growth factor on the function of a chronically implanted amperometric glucose sensor. Diabetes Technol. Ther. 2004; 6(2): 137–145.
- 120K. Udipi, et al., Modification of inflammatory response to implanted biomedical materials in vivo by surface bound superoxide dismutase mimics. J. Biomed. Mater. Res. 2000; 51(4): 549–560.
- 121T. Hickey, et al., In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J. Biomed. Mater. Res. 2002; 61(2): 180–187.
- 122D. Bhadra, et al., Pegnology: a review of PEG-ylated systems. Pharmazie. 2002; 57(1): 5–29.
- 123D. A. LaVan, T. McGuire, and R. Langer, Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 2003; 21(10): 1184–1191.
- 124P. Glikfeld, R. S. Hinz and R. H. Guy, Noninvasive sampling of biological fluids by iontophoresis. Pharm. Res. 1989; 6(11): 988–990.
- 125R. O. Potts, J. A. Tamada, and M. J. Tierney, Glucose monitoring by reverse iontophoresis. Diabetes Metab. Res. Rev. 2002; 18(Suppl 1): S49–S53.
- 126J. A. Tamada, et al., Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. JAMA 1999; 282(19): 1839–1844.
- 127G. Rao, et al., Reverse iontophoresis: noninvasive glucose monitoring in vivo in humans. Pharm. Res. 1995; 12(12): 1869–1873.
- 128J. A. Tamada, N. J. Bohannon, and R. O. Potts, Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nat. Med. 1995; 1(11): 1198–1201.
- 129C. C. Peck, K. Lee, and C. E. Becker, Continuous transepidermal drug collection: basis for use in assessing drug intake and pharmacokinetics. J. Pharmacokinet. Biopharm. 1981; 9(1): 41–58.
- 130B. Vogelstein, A. A. Kowarski, and P. S. Lietman, Continuous sampling as a pharmacokinetic tool. Clin. Pharmacol. Ther. 1977; 22(2): 131–139.
- 131K. E. Friedl, Analysis: signs of illness: when will technology provide greater advantage than the practiced eye of the clinician (or the military commander)? Diabetes Technol. Ther. 2003; 5(5): 857–859.
- 132R. Gillies, et al., Systemic effects of shock and resuscitation monitored by visible hyperspectral imaging. Diabetes Technol. Ther. 2003; 5(5): 847–855.